LeMaitre Vascular: The Compounder Keeps Compounding

Core Viewpoint - LeMaitre Vascular (NASDAQ: LMAT) has shown significant stock performance, with shares increasing approximately 35% since June 2025, outperforming the broader market by more than double [1]. Financial Performance - The stock experienced a notable jump of around 20% following a strong Q4 earnings report, which included an upward revision of expectations for 2026 [1].